Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imiquimod in clinical practice.

L Edwards1

  • 1Southeast Vulvar Clinic, Charlotte, North Carolina, USA.

Journal of the American Academy of Dermatology
|June 22, 2000
PubMed
Summary
This summary is machine-generated.

Topical imiquimod (Aldara) is an effective and safe treatment for anogenital warts, showing lower recurrence rates than standard therapies. Its antiviral and antiproliferative properties suggest potential for other skin conditions like molluscum contagiosum.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anaesthetic management of abdominal trauma.

BJA education·2025
Same author

Factors that influence the quality of the clinical supervision experience in a first contact physiotherapy (FCP) role - The perspectives of supervisors and supervisees - A qualitative analysis.

Musculoskeletal science & practice·2024
Same author

Management of acute cervical spinal cord injury in the non-specialist intensive care unit: a narrative review of current evidence.

Anaesthesia·2023
Same author

Bi-national outbreak of <i>Salmonella</i> Newport infections linked to onions: the United States experience.

Epidemiology and infection·2022
Same author

Point-of-care lung ultrasound in the assessment of suspected COVID-19: a retrospective service evaluation with a severity score.

Acute medicine·2020
Same author

The design and manufacture of 3D-printed adjuncts for powered air-purifying respirators.

Anaesthesia reports·2020
Same journal

Dermatologic conditions associated with HIV among US adults across different racial and ethnic groups: A retrospective cohort study using TriNetX.

Journal of the American Academy of Dermatology·2026
Same journal

Ethical Considerations in Same-Day Surgical Treatment of a High-Risk, Poorly Differentiated Squamous Cell Carcinoma.

Journal of the American Academy of Dermatology·2026
Same journal

The Ethics of the Handshake in Dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Dermatology images: Hidradenitis suppurativa.

Journal of the American Academy of Dermatology·2026
Same journal

Response to Guo et al., "Response to Huang et al.'s 'Real-world efficacy and safety of tofacitinib on the progression of skin sclerosis in patients with systemic sclerosis: an analysis of national multicenter data from the CRDC.'".

Journal of the American Academy of Dermatology·2026
Same journal

Genomic Predictors of Perineural Invasion in Cutaneous Squamous Cell Carcinoma: Insights from an MD Anderson Cohort.

Journal of the American Academy of Dermatology·2026
See all related articles

Area of Science:

  • Dermatology
  • Virology
  • Immunology

Background:

  • Anogenital warts are a common sexually transmitted infection caused by the human papillomavirus (HPV).
  • Traditional treatments for anogenital warts include cryotherapy, laser ablation, and topical chemotherapy, often associated with significant recurrence rates.
  • Imiquimod, a topical immune response modifier, has emerged as a therapeutic option for various skin conditions.

Purpose of the Study:

  • To evaluate the efficacy and safety of topical imiquimod for treating anogenital warts.
  • To compare the recurrence rates of imiquimod with standard therapies.
  • To explore the potential of imiquimod in treating other dermatological conditions.

Main Methods:

  • Systematic review of clinical trials investigating topical imiquimod for anogenital warts.

Related Experiment Videos

  • Analysis of reported efficacy, safety, and recurrence data.
  • Review of early reports on imiquimod's use for other skin diseases.

    • Main Results:

    • Topical imiquimod demonstrates significant efficacy and a favorable safety profile in treating anogenital warts.
    • Recurrence rates associated with imiquimod appear lower compared to many conventional treatments.
    • Clinical experience highlights imiquimod's importance in managing this condition, though not universally ideal.

    Conclusions:

    • Topical imiquimod is a valuable therapeutic option for anogenital warts, offering good efficacy and safety with potentially reduced recurrence.
    • Consideration of individual patient factors is crucial when selecting imiquimod.
    • Imiquimod's antiviral and antiproliferative mechanisms suggest promise for treating other skin conditions, including molluscum contagiosum and non-genital warts.